Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia.
<p>Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia.</p>
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1852026629592711168 |
|---|---|
| author | Daniel Geleta (17328210) |
| author2 | Gemeda Abebe (360995) Tsion Tilahun (19681363) Didimos Gezahegn (19681366) Netsanet Workneh (17328213) Getenet Beyene (3432986) |
| author2_role | author author author author author |
| author_facet | Daniel Geleta (17328210) Gemeda Abebe (360995) Tsion Tilahun (19681363) Didimos Gezahegn (19681366) Netsanet Workneh (17328213) Getenet Beyene (3432986) |
| author_role | author |
| dc.creator.none.fl_str_mv | Daniel Geleta (17328210) Gemeda Abebe (360995) Tsion Tilahun (19681363) Didimos Gezahegn (19681366) Netsanet Workneh (17328213) Getenet Beyene (3432986) |
| dc.date.none.fl_str_mv | 2024-09-16T17:39:38Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0310376.t003 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Prevalence_of_MDR_in_bacterial_isolates_in_neonatal_sepsis_at_JMC_Ethiopia_/27038923 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Medicine Microbiology Biotechnology Immunology Cancer Infectious Diseases Virology Environmental Sciences not elsewhere classified recorded using whonet jimma medical center 3 – 34 75 %), ceftazidime 100 %), penicillin 100 %), cefotaxime 3 %, 95 klebsiella pneumoniae </ stringent infection control 6 – 80 5 – 66 342 neonates suspected 4 – 71 8 – 93 8 – 31 prevalent resistance pattern 0 – 17 6 %, 95 negative staphylococci </ 1 %), ceftazidime 4 %, 95 8 %), chloramphenicol 2 %, 95 relevant clinical data 70 – 50 6 – 45 342 blood samples 1 – 45 100 %), trimethoprim 100 %), ceftriaxone 9 %, 95 7 %, 95 producers significantly contributing predominant isolates included phenotypic bacterial epidemiology 6 – 27 4 – 69 1 – 53 8 – 72 antimicrobial resistance profiles cases involving esbl 0 %), gentamicin 4 %), 8 %), 2 %), phenotypic epidemiology resistance profiles blood samples antimicrobial resistance significantly high randomly included negative bacteria infection rates infected neonates enhance data clinical sepsis bacterial isolates 6 %). 5 ). 1 ). 8 ), 8 %). multidrug resistance displayed resistance antimicrobial stewardship 2 %). 0 ), cons </ xlink "> study aimed standardized guidelines spectrum beta specifically esbl significant impact rundown crisis resistant strains producing strains positive bacteria notably higher notable surge neonatal sepsis molecular characterization may 2022 laboratory results july 2023 enhanced diagnostic driven decision deaths linked culture test bacteria isolated |
| dc.title.none.fl_str_mv | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_a577ee4db8722685da98643c8e0e8920 |
| identifier_str_mv | 10.1371/journal.pone.0310376.t003 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/27038923 |
| publishDate | 2024 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia.Daniel Geleta (17328210)Gemeda Abebe (360995)Tsion Tilahun (19681363)Didimos Gezahegn (19681366)Netsanet Workneh (17328213)Getenet Beyene (3432986)MedicineMicrobiologyBiotechnologyImmunologyCancerInfectious DiseasesVirologyEnvironmental Sciences not elsewhere classifiedrecorded using whonetjimma medical center3 – 3475 %), ceftazidime100 %), penicillin100 %), cefotaxime3 %, 95klebsiella pneumoniae </stringent infection control6 – 805 – 66342 neonates suspected4 – 718 – 938 – 31prevalent resistance pattern0 – 176 %, 95negative staphylococci </1 %), ceftazidime4 %, 958 %), chloramphenicol2 %, 95relevant clinical data70 – 506 – 45342 blood samples1 – 45100 %), trimethoprim100 %), ceftriaxone9 %, 957 %, 95producers significantly contributingpredominant isolates includedphenotypic bacterial epidemiology6 – 274 – 691 – 538 – 72antimicrobial resistance profilescases involving esbl0 %), gentamicin4 %),8 %),2 %),phenotypic epidemiologyresistance profilesblood samplesantimicrobial resistancesignificantly highrandomly includednegative bacteriainfection ratesinfected neonatesenhance dataclinical sepsisbacterial isolates6 %).5 ).1 ).8 ),8 %).multidrug resistancedisplayed resistanceantimicrobial stewardship2 %).0 ),cons </xlink ">study aimedstandardized guidelinesspectrum betaspecifically esblsignificant impactrundown crisisresistant strainsproducing strainspositive bacterianotably highernotable surgeneonatal sepsismolecular characterizationmay 2022laboratory resultsjuly 2023enhanced diagnosticdriven decisiondeaths linkedculture testbacteria isolated<p>Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia.</p>2024-09-16T17:39:38ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0310376.t003https://figshare.com/articles/dataset/Prevalence_of_MDR_in_bacterial_isolates_in_neonatal_sepsis_at_JMC_Ethiopia_/27038923CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/270389232024-09-16T17:39:38Z |
| spellingShingle | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. Daniel Geleta (17328210) Medicine Microbiology Biotechnology Immunology Cancer Infectious Diseases Virology Environmental Sciences not elsewhere classified recorded using whonet jimma medical center 3 – 34 75 %), ceftazidime 100 %), penicillin 100 %), cefotaxime 3 %, 95 klebsiella pneumoniae </ stringent infection control 6 – 80 5 – 66 342 neonates suspected 4 – 71 8 – 93 8 – 31 prevalent resistance pattern 0 – 17 6 %, 95 negative staphylococci </ 1 %), ceftazidime 4 %, 95 8 %), chloramphenicol 2 %, 95 relevant clinical data 70 – 50 6 – 45 342 blood samples 1 – 45 100 %), trimethoprim 100 %), ceftriaxone 9 %, 95 7 %, 95 producers significantly contributing predominant isolates included phenotypic bacterial epidemiology 6 – 27 4 – 69 1 – 53 8 – 72 antimicrobial resistance profiles cases involving esbl 0 %), gentamicin 4 %), 8 %), 2 %), phenotypic epidemiology resistance profiles blood samples antimicrobial resistance significantly high randomly included negative bacteria infection rates infected neonates enhance data clinical sepsis bacterial isolates 6 %). 5 ). 1 ). 8 ), 8 %). multidrug resistance displayed resistance antimicrobial stewardship 2 %). 0 ), cons </ xlink "> study aimed standardized guidelines spectrum beta specifically esbl significant impact rundown crisis resistant strains producing strains positive bacteria notably higher notable surge neonatal sepsis molecular characterization may 2022 laboratory results july 2023 enhanced diagnostic driven decision deaths linked culture test bacteria isolated |
| status_str | publishedVersion |
| title | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. |
| title_full | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. |
| title_fullStr | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. |
| title_full_unstemmed | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. |
| title_short | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. |
| title_sort | Prevalence of MDR in bacterial isolates in neonatal sepsis at JMC, Ethiopia. |
| topic | Medicine Microbiology Biotechnology Immunology Cancer Infectious Diseases Virology Environmental Sciences not elsewhere classified recorded using whonet jimma medical center 3 – 34 75 %), ceftazidime 100 %), penicillin 100 %), cefotaxime 3 %, 95 klebsiella pneumoniae </ stringent infection control 6 – 80 5 – 66 342 neonates suspected 4 – 71 8 – 93 8 – 31 prevalent resistance pattern 0 – 17 6 %, 95 negative staphylococci </ 1 %), ceftazidime 4 %, 95 8 %), chloramphenicol 2 %, 95 relevant clinical data 70 – 50 6 – 45 342 blood samples 1 – 45 100 %), trimethoprim 100 %), ceftriaxone 9 %, 95 7 %, 95 producers significantly contributing predominant isolates included phenotypic bacterial epidemiology 6 – 27 4 – 69 1 – 53 8 – 72 antimicrobial resistance profiles cases involving esbl 0 %), gentamicin 4 %), 8 %), 2 %), phenotypic epidemiology resistance profiles blood samples antimicrobial resistance significantly high randomly included negative bacteria infection rates infected neonates enhance data clinical sepsis bacterial isolates 6 %). 5 ). 1 ). 8 ), 8 %). multidrug resistance displayed resistance antimicrobial stewardship 2 %). 0 ), cons </ xlink "> study aimed standardized guidelines spectrum beta specifically esbl significant impact rundown crisis resistant strains producing strains positive bacteria notably higher notable surge neonatal sepsis molecular characterization may 2022 laboratory results july 2023 enhanced diagnostic driven decision deaths linked culture test bacteria isolated |